Is Troxerutin registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 1 valid registration of Troxerutin, including VENORUTON 300MG CAP (300 mg, Capsule, SAR 30.15).

Active substance

Troxerutin

SFDA 2

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
VENORUTON 300MG CAP	300 mg	Capsule · Oral use	20 Blister	SAR 30.15	NCE · Prescription	STADA ARZNEIMITTEL GmbH	Valid
VENORUTON GEL 2%	2 %	Gel · Topical	1 Tube	SAR 12.10	NCE · Prescription	NOVARTIS	Withdrawn by MAH · Not Marketed

Combinations containing Troxerutin

Heparinoid + troxerutin

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.